Validation of a Cell Proliferation Assay to Assess the Potency of a Dialyzable Leukocyte Extract Intended for Batch Release
Transferon<sup>®</sup> is a blood product with immunomodulatory properties constituted by a complex mixture of peptides obtained from a human dialyzable leukocyte extract (DLE). Due to its complex nature, it is necessary to demonstrate batch consistency in its biological activit...
Main Authors: | Gregorio Carballo-Uicab, José E. Linares-Trejo, Gabriela Mellado-Sánchez, Carlos A. López-Morales, Marco Velasco-Velázquez, Lenin Pavón, Sergio Estrada-Parra, Sonia Mayra Pérez-Tapia, Emilio Medina-Rivero |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-09-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/24/19/3426 |
Similar Items
-
Sequencing Analysis and Identification of the Primary Peptide Component of the Dialyzable Leukocyte Extract “Transferon Oral”: The Starting Point to Understand Its Mechanism of Action
by: Luis Vallejo-Castillo, et al.
Published: (2020-10-01) -
Histopathology of murine toxoplasmosis under treatment with dialyzable leukocyte extract
by: Beatriz Eugenia Fuentes-Castro, et al. -
Bovine Dialyzable Leukocyte Extract IMMUNEPOTENT CRP: Evaluation of Biological Activity of the Modified Product
by: Moisés Armides Franco-Molina, et al.
Published: (2021-04-01) -
Effect of dialyzable leukocyte extract, sodium butyrate, and valproic acid in the development of anergy in murine leprosy
by: Oscar Rojas-Espinosa, et al.
Published: (2020-01-01) -
Transferon™, a peptide mixture with immunomodulatory properties is not immunogenic when administered with various adjuvants
by: Sandra Avila, et al.
Published: (2017-01-01)